Theralase® cool laser therapy can benefit your patients, increase your revenue and are a great value-added service for physiotherapists. Not only will this drug-free therapy add cash to your bottom line, but it will also complement the effects of your treatments. When applied correctly, it can help treat many of the conditions* your patients suffer with.
Cool laser therapy ("CLT") also referred to as low-level laser therapy or photobiomodulation, has been actively used for nearly 50 years. To date, there are more than 4000 published studies worldwide involving low-level laser therapy with approximately 400 of those being double-blind studies.
Theralase® therapeutic lasers expose tissue to light energy (photons) of two different wavelengths, within the visible and near infrared spectrum, triggering a chain of different chemical reactions within the cell for tissue healing and pain reduction. Theralase® superpulsed laser technology can penetrate up to 5 inches in depth, stimulating even the deepest of conditions*. It is a highly effective, non-invasive, and pain-free treatment alternative for a wide range of conditions*.
Theralase® therapeutic lasers can effectively treat or help improve many physio conditions* such as:
- Neck Pain
- Migraines / Headache
- Rotator Cuff Syndrome
- Muscle Strains / Ligament Sprains
- Carpal Tunnel Syndrome
- Lumber Arthrosis
- Tennis / Golfer’s Elbow
- Hip Bursitis
- Knee Pain / Ligament Injuries
- Plantar Fasciitis
- Achilles Tendinitis
Theralase® patented, super-pulsed, non-thermal Class 3B lasers activate all three known cellular pathways.
660 nm Adenosine Triphosphate (ATP) Pathway
Theralase® stimulates the mitochondria of the cell to produce more Adenosine Triphosphate (ATP or basic cell energy) to accelerate tissue repair. (Proceedings of the International Society for Optics and Photonics, 2015)
905 nm Nitric Oxide (NO) Pathway
Independent research proves that the proprietary Theralase® 905nm superpulsed laser technology increases the production of Nitric Oxide (NO) by over 700%, increasing vasodilation and decreasing inflammation versus other competitive wavelengths. (Lasers in Surgery and Medicine, 2009)
905 nm Lipid Absorption Pathway
Theralase® laser technology effectively removes the pain signal at source by rebalancing the sodium potassium pathway. (Harvard Medical School, 2010)
OVER 100 TREATABLE CONDITIONS*
Theralase® cool laser therapy systems have been approved by both Health Canada and the FDA for the safe and effective treatment of pain associated with chronic knee conditions.
*While over 4,000 clinical studies worldwide have proven the efficacy of cold laser technologies in treating a host of other conditions, Theralase® lasers have not received explicit approval for these applications. In-clinic treatment of other conditions is at the sole discretion of the healthcare practitioner and may include the following:
Image Source: 123RF.com / dmytro demianenko
Unlike LED and competitor laser technologies, Theralase’s® patented TLC-2000 dual wavelength superpulsed cold lasers penetrate up to 5 inches into tissue to help accelerate healing, reduce inflammation, and eliminate pain at even the deepest sites.
WATCH RECORDED WEBINAR
Using Advanced Technology to Improve Your Pain Management Techniques
– Dr. Elizabeth Angelevski, D.C
As practitioners, we all seek techniques and methodologies to enhance our treatment efficacies. For thousands of practitioners and patients, Theralase laser therapy has proven to be the most effective, natural, non-invasive treatment modality that has complemented their traditional methodologies – healing wounds, preventing surgeries, accelerating post-surgical healing and generally lessen or totally eliminate the body’s pain signals.
Join this informative mini-webinar, the first in a series of 6, to hear about what makes this laser light so effective at stimulating physiological regenerative effects in the body, enabling you to better treat your patients (and grow your business!)
Dr. Elizabeth Angelevski, Director of Clinical Education and Training, B.Sc., D.C.
Dr. Angelevski graduated from McMaster University with a Bachelor of Science (Honours) in Kinesiology. Her interest in the workings of the human body and mind, as well as in movement and rehabilitation, brought her to the Canadian Memorial Chiropractic College. After 4 years of intense study, she graduated with a Doctor of Chiropractic degree in 2009. Dr. Angelevski returned to McMaster University to complete the Contemporary Medical Acupuncture program and has completed post-graduate training in Custom Orthotic Therapy. She has also completed a certificate program in Advanced Clinical Anatomy.
Dr. Angelevski is currently the Director of Clinical Education and Training at Theralase and runs a successful clinic at the Theralase Pain Therapy Clinic. She has a keen professional interest in helping patients achieve optimal health and well-being through the use of laser therapy. She is dedicated to improving their quality of life through laser treatment programs that are specifically designed for each patient. Dr. Angelevski strongly believes that education is an essential component. Therefore, each patient is guided to effectively manage and prevent the condition from recurring.
In this 15-minute “Theralase short”, Dr. Elizabeth Angelevski, D.C., will focus on the appropriate management of carpal tunnel syndrome that includes the use of Theralase® Cool Laser Therapy (“CLT”).
Live Webinar – November 28, 2018
In this webinar, Dr. Elizabeth Angelevski, D.C., will focus on the factors that make a therapeutic laser device effective. Learn how the new advanced TLC-2000 Cool Laser Therapy (“CLT”) system, delivering the correct dose and depth of penetration, will get your patients back in the swing of things!
Live Webinar – November 21, 2018
In this 15-minute “Theralase short”, Dr. Elizabeth Angelevski, D.C., will focus on the appropriate management of Achilles tendinopathy using Theralase® Cool Laser Therapy (“CLT”).
Live Webinar – November 14, 2018